ANACONDA PHARMA has a total of 27 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), France and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ASKAT INC, SEQUOIA PHARMACEUTICALS INC and KOWA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | France | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Argentina | 3 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | Brazil | 2 | |
#8 | Hong Kong | 2 | |
#9 | Israel | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Compere Delphine | 21 |
#2 | Blumenfeld Marta | 21 |
#3 | Gauthier Jean-Michel | 9 |
#4 | Francon Patricia | 6 |
#5 | Hutin Michel | 6 |
#6 | Ciufolini Marco A | 4 |
#7 | Gauthier Jean Michel | 2 |
#8 | Marco A Ciufolini | 1 |
#9 | Delphine Compere | 1 |
#10 | Marta Blumenfeld | 1 |
Publication | Filing date | Title |
---|---|---|
FR3000490A1 | PROCESS FOR SYNTHESIZING HYDRAZINE USEFUL IN THE TREATMENT OF PAPILLOMA VIRUS | |
FR2990134A1 | PHARMACEUTICAL COMPOSITION OF PAPILLOMA VIRUS INHIBITOR | |
FR2923825A1 | NOVEL INHIBITORS OF HUMAN PAPILLOMA VIRUS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME. | |
FR2901273A1 | INHIBITORS OF HUMAN PAPILLOMA VIRUS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |